Location: Home
  • search
  • go
  • Relate News
  • 9/14/2018Chinese Drug-releasing Heart Stent Clears Clinical Trials in Europe
  • 9/14/2018Can A Cancer Drug Originated In China Be A Success In The U.S.?
  • 9/14/2018Takeda Wins Chinese Approval of Its $62B Shire Acquisition Deal
  • 9/14/2018EU, U.S. and Canada Investigating Second Impurity in Huahai's Valsarta...
  • 9/14/2018China's Largest Drug Retailer Plans Next Milestones to Scale Business ...
  • 9/14/2018Sanofi Reorganizes to Spotlight China Following Senior Executive Chang...
  • 9/14/2018WiCON Publishes the China Pharmaceutical Guide 2018 (13th Edition)
  • 9/13/2018SMIA-led National Centralized Drug Tender Purchase Trial To Be Initiat...
  • 9/13/2018NMPA Releases List of Reference Formulations for Generic Drug Equivale...
  • 9/13/2018Two Underwhelming China Tech IPOs in NY Spell Trouble for Those in Lin...
  • 9/13/2018BioCad and Shanghai Pharma Sign MOU for Two JVs
  • 9/13/2018EU Regulators Issue Notice on a Chinese Anticancer API After Rejected ...
  • 9/13/2018Phase II of HKEx Biotech Experiment Begins with Cautious Hua Medicine ...
  • 9/13/2018Novocure and Zai Lab Announce Partnership & License Deal for Tumor...
  • 9/13/2018Athenex and Hanmi Pharma Realign Their Joint Projects
  • 9/13/2018Allergan and AliHealth to Launch Digital Platform for Medical Aestheti...
  • 9/12/2018Tasly Licenses US Rights of TCM Angina Drug to Arbor Pharma in $50M De...
  • 9/11/2018SMIA’s Official Responsibilities and Internal Organization Approved
  • 9/11/2018NMPA's Official Responsibilities and Internal Organization Approved
  • 9/11/2018SAMR's Official Responsibilities and Internal Organization Approved
  • 9/11/2018NHC's Official Responsibilities and Internal Organization Approved
  • 9/11/2018Snapshot of Chinese Public Hospital Vaccine Consumption 2017
  • 9/11/2018CDE Publicizes Batch 32 of Drug Applications To Be Granted Priority Re...
  • 9/11/2018WuXi Biologics and Inhibrx Enter an Exclusive Partnership for GMP Manu...
  • 9/11/2018Innovent Receives Chinese IND Approval for mAb Drug Candidate
  • 9/11/2018China CDMO Market 2018-2021: The R&D Cost of New Drugs Continues t...
  • 9/10/2018NMPA Issues New Announcement (2018#64) for Clinical Data Self-Inspecti...
  • 9/10/2018The TKI Lung Cancer Market in China
  • 9/7/2018Recent Executive Moves
  • 9/7/2018Luye Pharma's Prostate Cancer Drug Initiates Phase III Clinical Trials...
  • Page:255/720 Total number of articles:21577: [First][<<] [253] [254] [255] [256] [257] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group